-
Selexipag, sold
under the
brand name Uptravi, is a
medication developed by
Actelion for the
treatment of
pulmonary arterial hypertension (PAH). Selexipag...
- iloprost, bosentan, ambrisentan, macitentan, and sildenafil, tadalafil,
selexipag, riociguat. Lung
transplantation may be an
option in
severe cases. The...
-
phosphate (2014),
isavuconazonium (2015),
aripiprazole lauroxil (2015),
selexipag (2015),
latanoprostene bunod (2017),
benzhydrocodone (2018), tozinameran...
- (prostaglandin I2, epoprostenol)
Prostaglandin E1 (alprostadil)
Ralinepag Selexipag Taprostene TRA-418
Treprostinil Antagonists: RO1138452 TP (TXA2)Tooltip...
-
drugs Several anesthetic agents Oral
contraceptive pills Statins Warfarin Selexipag The
exact mechanism of
action of
gemfibrozil is unknown; however, several...
- (prostaglandin I2, epoprostenol)
Prostaglandin E1 (alprostadil)
Ralinepag Selexipag Taprostene TRA-418
Treprostinil Antagonists: RO1138452 TP (TXA2)Tooltip...
- (prostaglandin I2, epoprostenol)
Prostaglandin E1 (alprostadil)
Ralinepag Selexipag Taprostene TRA-418
Treprostinil Antagonists: RO1138452 TP (TXA2)Tooltip...
-
right ventricle and
reduced PVR (Pulmonary
Vascular Resistance).
Uptravi (
Selexipag):
Uptravi was
originally it was
developed by
Nippon Shinyaku to treat...
-
causes relaxation of
smooth muscle cells thus
acting as a vasodilator.
Selexipag acts as a PGI2
receptor agonist to also
activate adenylate cyclase. Epoprostenol...
- (prostaglandin I2, epoprostenol)
Prostaglandin E1 (alprostadil)
Ralinepag Selexipag Taprostene TRA-418
Treprostinil Antagonists: RO1138452 TP (TXA2)Tooltip...
